Skip to content

Clinical trials

Observational Pulmonary Disease, Chronic Obstructive trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Observational Country / region: Norway Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20082
20092
20112
20122
20132
20151
20162
20182
20191
20201
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
LHL Helse2
Norwegian University of Science and Technology2
Boehringer Ingelheim1
GlaxoSmithKline1
Haukeland University Hospital1
Helse Stavanger HF1
Orion Corporation, Orion Pharma1
Oslo University Hospital1
St. Olavs Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive20
Asthma3
Anxiety Disorders2
Hypoxia2
Airway Obstruction1
Cardiovascular Diseases1
Clinical Deterioration1
Depressive Disorder1
Dyspnea1
Fatigue1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.